ÂÜÀòÂÒÂ×

Jamieson Bondarenko, CFA, CMT, is an experienced finance professional currently serving as the Owner of JGRNT Capital Corp. since October 2017 and as a capital markets specialist at CHAR Technologies Ltd. and MustGrow Biologics Corp. since early 2023 and September 2018, respectively. Additionally, Jamieson holds the position of Chairman of the Board at BriaCell Therapeutics Corp. since March 2019. Previously, significant roles were held at Eight Capital as Principal and Managing Director of Equity Capital Markets and at Dundee Capital Markets in various leadership positions over six years. Early career experience includes positions at Wellington West Capital Markets Inc. and HSBC Global Banking and Markets. Jamieson Bondarenko earned a Bachelor of Business Administration from Wilfrid Laurier University in 2006.